Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-26 @ 1:24 AM
Study NCT ID:
NCT03463733
Status:
UNKNOWN
Last Update Posted:
2020-10-08
First Post:
2018-03-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
Sponsor:
M.E. van Linde
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-01
First Submit QC Date:
None
Study First Post Date:
2018-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-06
Last Update Post Date:
2020-10-08
Last Update Post Date Type:
ACTUAL